ADVANCED OPTICS ELECTRONICS FILES 10-SB TO BECOME FULLY
7/1/98 8:46
=
Reporting;
Business Editors and Medical Writers
Technology Partner, BioModa, Inc., Initiates Program to
Market Lung Cancer Test to The People's Republic of China
ALBUQUERQUE, N.M.--(BW HealthWire)--July 1, 1998--Advanced Optics
Electronics, Inc. (OTC BB:ADOT) announced today they have filed Form
10-SB with the SEC to become a fully reporting company.
Advanced Optics considers this SEC filing to be a significant
step toward the Company's goal of a full NASDAQ listing. As a fully
reporting company, Advanced Optics also becomes a more credible market
candidate, capable of attracting investment analyst coverage, thus
ensuring better market support both domestically and internationally.
Advanced Optics also announced today that their technology
partner, BioModa, Inc. has secured additional technology patents in
Australia and with the Russian Federation, and has patents pending in
14 other countries. These patents further protect BioModa's
proprietary early detection test for lung cancer and BioModa's
proprietary lung cancer treatment program.
BioModa, Inc., after two years of negotiations, has additionally
embarked on a new program in cooperation with the Shanghai Center on
New Drug Development in The People's Republic of China (PRC). BioModa
will work with the Shanghai Center (owned jointly by the city of
Shanghai and the Chinese Government) to provide Shanghai and the
country of China with an economical turn-key medical package that will
accurately diagnose various forms of lung cancer up to six years
earlier than any test currently available.
The objective of this program is to address an urgent need among
the Chinese population. The PRC reports that over 900,000 Chinese
people die each year from lung cancer. Although China has over 300
million smokers, a large number of lung cancer cases can be attributed
to working in factories where caustic chemicals and noxious fumes are
found.
This press release contains forward-looking statements with
respect to the results of operations and business of the Company that
involves risk and uncertainties. The Company's actual future results
could materially differ from those discussed. Risks and uncertainties
of the Company are detailed from time to time in the Company's
periodic reports filed with the Securities and Exchange Commission.
ABOUT ADVANCED OPTICS:
Advanced Optics Electronics, Inc. (OTC BB:ADOT - news) is a
developer of patented electronic display technology, utilizing ADOT's
proprietary Spatial Light Modulator light valve. This industry-leading
technology can be utilized in the production of "television quality"
advertising billboards, medical testing equipment, military displays,
computer monitors and high definition video transmission to name a
few. Advanced Optics Electronics actively seeks partnerships with
companies in fields that could benefit from ADOT's technology.
ADOT also owns over 27% of BioModa, Inc., an emerging
biotechnology company specializing in breakthrough cancer diagnostics
and therapy. Advanced Optics can also design, manufacture and
distribute the scanning devices for the lung cancer tests using
Advanced Optics Electronics' proprietary display technology.
--30--pb/sf* as/sf
CONTACT: Advanced Optics Electronics, Inc.
505/797-7878
adot.org
KEYWORD: NEW MEXICO
INDUSTRY KEYWORD: COMED COMPUTERS/ELECTRONICS MEDICINE
PHARMACEUTICAL BIOTECHNOLOGY AEROSPACE/DEFENSE PHARMACEUTICAL
TELECOMMUNICATIONS
URL: adot.org
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com |
